Recent

% | $
Quotes you view appear here for quick access.

Мабвакс Терапевтика Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • skyhigh_x skyhigh_x Jan 29, 2013 6:07 PM Flag

    TELK

    In short, all development stage biotech company shares present some degree of risk in investment. TELK at present is significantly undervalued relative to its cohorts. TELK at the present valuation is more than just a buy; it may be an aggressive buy.

 
TELK
0.00(0.00%)